Atomized intranasal vs intravenous fentanyl for acute Renal colic management

Atomized intranasal vs intravenous fentanyl for acute Renal colic management in ED: A randomized double-blinded clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150509022181N4

Enrollment

120

Registered

2019-06-19

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group: In the intervention group, fentanyl was administered intranasally with intravenous placebo. Fentanyl, a sublimaz brand, was prescribed at a dose of 1 microgram per

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 16-65 years old clinical symptoms of acute renal colic visual analog scale (VAS) greater than or equal to 7

Exclusion criteria

Exclusion criteria: allergy to opiates and NSAIDs known or suspected abdominal aortic dissection or aneurism peritonitis hemodynamic instability pregnancy, breastfeeding anticoagulant therapy organs failure renal transplantation

Design outcomes

Primary

Measure	Time frame
Pain control time. Timepoint: At the beginning of the study, 10, 20, 30, 40, 60 minutes after the administration of the drug. Method of measurement: VAS (Visual Analog Scale).	—

Secondary

Measure	Time frame
The physician and patient satisfaction. Timepoint: The end of study. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Torabi

Kerman University of Medical Sciences

mtorabi1390@yahoo.com+98 34 3223 5011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026